chrisvoncsefalvay/vaers-outcomes huggingface dataset:
felt Fluey; a red, warmish circle under the injection site; Larger than silver dollar circular rash, about the size of a small can; a red, warmish circle under the injection site; Intense itchiness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Intense itchiness), INFLUENZA (felt Fluey), VACCINATION SITE WARMTH (a red, warmish circle under the injection site), RASH (Larger than silver dollar circular rash, about the size of a small can) and VACCINATION SITE ERYTHEMA (a red, warmish circle under the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced PRURITUS (Intense itchiness). On 30-Jan-2021, the patient experienced INFLUENZA (felt Fluey), VACCINATION SITE WARMTH (a red, warmish circle under the injection site), RASH (Larger than silver dollar circular rash, about the size of a small can) and VACCINATION SITE ERYTHEMA (a red, warmish circle under the injection site). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PRURITUS (Intense itchiness), INFLUENZA (felt Fluey), VACCINATION SITE WARMTH (a red, warmish circle under the injection site), RASH (Larger than silver dollar circular rash, about the size of a small can) and VACCINATION SITE ERYTHEMA (a red, warmish circle under the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Within 24 hours post vax, pt. developed an injection site reaction characterized by redness and swelling extending from the shoulder to the elbow.  Pt was treated with an unspecified oral antibiotic and recovered within 4 days.
Extreme body aches, fever and headache.  Took Tylenol for headache and Ibuprofen for fever and body aches.
heart attack; This case was reported by a consumer via media and described the occurrence of heart attack in a 51-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced heart attack (serious criteria GSK medically significant). On an unknown date, the outcome of the heart attack was unknown.   It was unknown if the reporter considered the heart attack to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient's friend. The age at vaccination was not reported. The patient got the shingle shot and had heart attack, which was more difficult to recover. The follow-up would not possible as no contact details were available.
Injection attempt was given in the right arm first. injection had empty vaccine vial. Sterile needle was used throughout procedure, needle stick protocol does not apply.  Patient was informed of administration mistake, verbally acknowledged understanding.  Influenza vaccine was then administered to left arm.
I've lost 13 pounds in the last 23 days. I lost 6 of those pounds within the first 5 days. It is hard to keep food down because I projectile vomit 20 minutes after eating and I am never hungry anymore. I only know I need to eat if I feel like I am going to faint. A couple days after the first dose and the night of the second dose I had severe pain, the worst I've experienced in my life, and it lasted for about 8 hours each time. I felt like all my nerves and all my bones were on fire.  It was terrifying. My vision gets grey and splotchy and there is a swollen lump in my armpit that is half the size of a baseball. I have not been able to sleep a full 8 hours a night since I received this vaccine due to pain and discomfort.  I take vitamin C & D, got a vitamin C IV, aspirin, my mom had to massage me for hours so I could stop screaming and crying. I am still not ok and I am scared.
PSORIATIC ARTHRITIS AGGRAVATED; ANEMIA; VACCINATION SITE PAIN; This spontaneous report received from a patient via other manufacturer and concerned an adult male of unspecified race and ethnic origin. The patient was enrolled in a non-Company sponsored solicited program. The patient's height, and weight were not reported. The patient's concurrent conditions included: psoriatic arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported, expiry: unknown) dose was not reported, 1 total administered on an unspecified date in OCT-2021 for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. Non-company suspect drugs included: adalimumab (Humira) (solution for injection in pre-filled pen, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported for psoriatic arthritis. No concomitant medications were reported. On an unspecified date, the patient experienced psoriatic arthritis aggravated (psoriatic arthritis flare), anemia, and vaccination site pain (sore arm following covid vaccine). It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with adalimumab was not reported. The outcome of the vaccination site pain, anemia and psoriatic arthritis aggravated was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220339476-COVID-19 VACCINE AD26.COV2.S- Psoriatic arthritis aggravated. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY( psoriatic arthritis.) Therefore, this event(s) is considered not related.
On 9/21/00, pt experienced a fever of 102.6, headache, muscle pain, joint pain, nausea without vomiting, and diarrhea. Medical attention was sought. No further info is available.
On the same day in the evening had itchy throat and felt itchy all over my body. The next morning woke up in a lot of pain . Had very red patches all over my body. They very burning a lot and felt very hot . When touching felt like there were needles in those areas . On that day had more difficulty breathing but it was not to severe . The rush got even worse the next day and spread to more places . After about 1 week of pain they stated to peel . Now 2 weeks later it is still peeling .
Patient's right side of neck starting swelling after 10-15 minutes of vaccination. Patient received Benadryl and the swelling slowly went down. Patient stayed for another 20 minutes for watch and left.
This spontaneous report as received from a licensed practical nurse refers to multiple unspecified patients of unknown age and gender. Patient pertinent medical history, concurrent condition and concomitant medication were not reported. No previous drug reactions/allergies were reported. On unknown dates these unspecified patients were vaccinated with improperly stored VARIVAX (strength, dosing details, anatomical location, lot# and expiration date were unknown. There were previous temperature excursions but, no information was provided on previous excursions. The temperature excursions were detected by a data logger. No product quality complaint was involved. Additional information has been requested.
Patient is 16 weeks pregnant and came in for COVID vaccine. Patient was administered Bivalent. Patient was monitored and had no adverse events noted.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No relevant concomitant medications were reported.
Began having diarrhea; A spontaneous report was received from a consumer who is an unidentified patient that received Moderna's covid-19 vaccine(mRNA-1273) and experienced diarrhea.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 29-Dec-2020, at 1:50 PM, the patient received their dose of mRNA-1273 (Batch Number: Unknown) for prophylaxis of COVID-19 infection.  On 29-Dec-2020, around 6:00 PM, the patient experienced diarrhea.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event diarrhea was not reported.  The outcome of the event diarrhea was not reported.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Pt recv vax & devel inj site rxn of redness & warmth. Described as "cellulitis".
My arm is still really sore; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   In November 2020, the patient received the 2nd dose of Meningococcal B vaccine. In November 2020, less than a week after receiving Meningococcal B vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Meningococcal B vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 2nd dose of Meningococcal B vaccine and experienced sore arm.
Itches; more patient scratches it, the more it sores; Irritation; rash in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itches), PAIN (more patient scratches it, the more it sores), SKIN IRRITATION (Irritation) and VACCINATION SITE RASH (rash in the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced PRURITUS (Itches), PAIN (more patient scratches it, the more it sores), SKIN IRRITATION (Irritation) and VACCINATION SITE RASH (rash in the injection site). At the time of the report, PRURITUS (Itches), PAIN (more patient scratches it, the more it sores), SKIN IRRITATION (Irritation) and VACCINATION SITE RASH (rash in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  The patient applied creams and ointments give by dermatologist to treat symptoms.
pt apparently devel a mild case of measles, mumps & rubella onset 7 days p/vax;course of illness lasting 7-10days (fever, episodes of rash, lymphadenopathy & swollen cheeks);
Systemic: Metastatic Stage 4 Melanoma, Broken hip, Significant blood clot in right leg, UTI, Multiple bilateral pulmonary nodules-Severe
Child received 1st Hep-B shot on 2/2/2000. On 2/4/2000, the child complained of 3 small hives on left back and shoulder with itchiness and redness. No diarrhea. Mom went to PMD (surgeon) for something else and be examined the hives, but could not determine if they were related to vaccine.
acute, hot swelling of upper arm (5 -  6 days), low  grade fever (99.9 - 100.8, three days), body aches, fatigue, headache . Treated with alternating heat and cold at injection site, ibuprofen and tylenol.
The last time patient had the flu was when patient last got a flu shot sometime before 1980; Initial information received on 01-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves unknown gender and age patient who stated the last time patient had the flu was when patient last got a flu shot sometime before 1980 while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported; formulation: unknown) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious event "the last time patient had the flu was when patient last got a flu shot sometime before 1980" (influenza) (unknown latency).  It is unknown if there were lab data/results available.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event the last time patient had the flu was when patient last got a flu shot sometime before 1980.
1/2 hour after vaccine given, forearms and hands became red and blotchy, back also red
Sore arm; A spontaneous report was received from a consumer concerning a 71-year-old, male patient who received Moderna (mRNA-1273) and experienced sore arm.   The patient's medical history included high blood pressure. Relevant concomitant medications included Warfarin (blood thinning treatment) and unknown blood pressure medicine.   On 06 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot: 25LA0E) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 06 Jan 2021, after administration, the patient experienced a sore arm, but denied adverse events, stated that he was very well. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was unknown.   The outcome of the event sore arm was unknown.; Reporter's Comments: This case concerns a 71-year-old male who experienced a NS unexpected event of Limb discomfort.  Event onset occurred the same day after the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
100mm diameter induration with erythema to site of .5cc SC vaccination of Anthrax.
pt recvd 2nd dose of pneumococcal vax on 21NOV91 & on 22NOV92 devel fluid retention for the next 2 to 3 days; pt recovered; no further details were provided;
Received the vaccine around 9am. Chest pain/palpitations started around 12pm, lasting about an hour. Tuesday, August 24, 2021, chest pain on and off all day, stomach pains.  Wednesday , August 25, 2021, Crohn?s disease (that was in remission) starting flaring up. Stomach pains, joint pains. Wednesday, August 25, 2021, could barely grip a shopping cart from joint swelling/pain, diarrhea, chest pain. SOB Thursday, August 26, 2021, more diarrhea, joint pain/swelling, chest pains on and off all day , Shortness of breath (SOB) on and off all day.  Friday, August 27, 2021 (today), joint swelling/pain, stomach pain, chest pain (5am), SOB
Information has been received from a physician concerning a 13 year old female patient with a history of exposure to mumps who on 25-OCT-2007 was vaccinated with the first dose of MMR II (lot number not reported). On 31-DEC-2009 the patient experienced mumps. On an unspecified date, the patient developed fever of 103 F and blood in stool which lasted for 1 day. The patient was diagnosed on 24-DEC-2009. The patient experienced parotitis. On 24-DEC-2009. The patient's IgM was <1:10, her IgG was 5.68 and her serum amylase was 346. The outcome of the patient was not reported. Follow-up information was received which reported that on 11-JAN-2010, the patient developed afebrile bilateral parotitis. It was diagnosed on 11-JAN-2010. On 11-JAN-2010, the patient's IgM was <1:10, serum immunoglobulin G (IgG) was 7.09 and serum amylase was 65. The outcome of the patient was not reported. This is one of several reports from the same source. Additional information is not expected.
PATIENT STATED SHE FELT VERY TIRED, FEVERISH, PAINFUL ARM, AND SLEPT A LOT  FOR A FEW DAYS. SHE NOTICED THE RASHES ON THE LEFT UPPER ARM THE MORNING AFTER VACCIEN GIVEN. SHE WENT TO THE EMERGENCY DEPARTMENT ON 07-30-2023  AND RECEIVED TREATMENT AND SENT HOME WITH SOME PRESCRIPTIONS. SHE IS NOW STATBLE AND RESTING.  SHE WILL BE FOLLOWING UP WITH HER PCP.
still got flu/Suspected vaccination faliure; still got the flu; Got sick; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a 18-year-old patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, unknown after receiving Flu vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), sickness and influenza. On an unknown date, the outcome of the vaccination failure, sickness and influenza were unknown.   The reporter considered the vaccination failure, sickness and influenza to be related to Flu vaccine.     Additional Information: GSK Receipt Date: 05-Jan-2023 Reporter's Comments: The reporter was patient's parent. The reporter reported that the patient had only received the flu shot once as toddlers.  The patient got sick that year and never had the flu or shot since.  As a family, decided that it would be better to option out of the flu shot.  The consumer stated that kids rarely get sick and they tried to refrain from prescription meds as much as possible. The CDC and FDA are money makers.  These people could not be encouraging anyone to vaccinate their children.  They should be encouraging people to do what would best for their family. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of flu were unknown at the time of reporting. This case had been linked with US2023AMR001616, reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR001616:Same reporter
Pustular rash, painful. Only on right side of leg and abdomen; Pustular rash, painful. Only on right side of leg and abdomen; This is a spontaneous report from a contactable consumer or other non hcp.     A 34-years-old female Non-Pregnant patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Right on 10Aug2021 12:00 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant was not reported. The patient previously took cipro [ciprofloxacin] and experienced hypersensitivity. No other medications the patient received within 2 weeks of vaccination. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was Reported that, the patient experienced pustular rash, painful, only on right side of leg and abdomen on 19Aug2021 with outcome of not recovered Therapeutic measures were taken as a result of pustular rash, painful. only on right side of leg and abdomen (rash pustular), pustular rash, painful. only on right side of leg and abdomen (rash).  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up
Information has been received from a 21 year old female with no medical history who about 2 months ago in approximately April 2009, was vaccinated with her 1st dose of GARDASIL. Concomitant medication included hormonal contraceptives (unspecified). There were no labs and diagnostic tests performed. Subsequently the patient was spotting and her menstrual cycle was changing after getting GARDASIL. The patient hadn't sought medical attention. At the time of report the patient hadn't recovered. No further information is available.
This is a spontaneous report obtained from a contactable physician through a Pfizer sales representative. A 4-month-old female patient of an unspecified race and ethnicity received the first dose of PREVNAR 13 on an unknown date, at the age of at 2 months, single dose, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, after the first vaccination and before the second shot, the patient experienced illness and fever. She was diagnosed with streptococcal Pneumonia and haemophilus influenzae. Clinical outcome was unknown at time of this report.; Sender's Comments: Based on the information provided in the case, a lack of efficacy with PREVENAR 13 in this patient cannot be excluded. Further information like serotyping results is needed for a full medical assessment.
Edema of right axillary and right chest wall 4 days after Covid-19 booster
This spontaneous report as received from a licensed practical nurse refers to a 12 year old patient of unknown gender. The patient's  medical history, concurrent conditions and concomitant medications were not reported. On 08-JUN-2015, the patient was vaccinated with a dose of GARDASIL (lot # K004204, expiration date 12-JAN-2017, dose and route were not reported) that had experienced an excursion. No adverse reaction was reported. This is one of several reports received form the same reporter. Additional information has been requested.
Shingles; This case was reported by a other health professional via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In April 2019, the patient received the 1st dose of Shingrix. In April 2019, 7 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient's DOB (date of birth) was not available.  The age at vaccination was not reported. One month back in April 2019, the patient received 1st dose of Shingrix vaccine. One week after receiving the vaccine, the patient was diagnosed with Shingles by physician. Shingles had resolved at the time of reporting.  The patient consented to follow up.  No other information available.
Injection hurt a little when administered, but 4-5 days later started to hurt more and injection site was ulcerated. Pt went to primary care provider and was told she had a reaction to the injection. No treatment was provided, when pt presented at pharmacy on 10/23/12 to tell us about this, the area had scabbed over and was healing.
Patient reported to work at another physician office (housekeeping) after waiting 30 minutes at vaccinating site and presented with itching all over 1 hour after injection ("really bad per patient report").  Patient seen by onsite provider and given Solu-Medrol 125 mg IM and Benadryl 50 mg IM.  Patient followed up with PCP on 2/26/21 and prescribed hydroxyzine for urticaria.